These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


371 related items for PubMed ID: 19696144

  • 41. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
    Showkat M, Beigh MA, Bhat BB, Batool A, Andrabi KI.
    Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
    [Abstract] [Full Text] [Related]

  • 42. Intestinal cell kinase is a novel participant in intestinal cell signaling responses to protein malnutrition.
    Bolick DT, Chen T, Alves LA, Tong Y, Wu D, Joyner LT, Oriá RB, Guerrant RL, Fu Z.
    PLoS One; 2014 Oct; 9(9):e106902. PubMed ID: 25184386
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of phosphatidylinositol 3-kinase- and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells.
    Davies CC, Mason J, Wakelam MJ, Young LS, Eliopoulos AG.
    J Biol Chem; 2004 Jan 09; 279(2):1010-9. PubMed ID: 14581487
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Increased milk protein synthesis in response to exogenous growth hormone is associated with changes in mechanistic (mammalian) target of rapamycin (mTOR)C1-dependent and independent cell signaling.
    Sciascia Q, Pacheco D, McCoard SA.
    J Dairy Sci; 2013 Apr 09; 96(4):2327-2338. PubMed ID: 23462168
    [Abstract] [Full Text] [Related]

  • 46. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
    Oshiro N, Takahashi R, Yoshino K, Tanimura K, Nakashima A, Eguchi S, Miyamoto T, Hara K, Takehana K, Avruch J, Kikkawa U, Yonezawa K.
    J Biol Chem; 2007 Jul 13; 282(28):20329-39. PubMed ID: 17517883
    [Abstract] [Full Text] [Related]

  • 47. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase.
    Hou X, Arvisais EW, Davis JS.
    Endocrinology; 2010 Jun 13; 151(6):2846-57. PubMed ID: 20351317
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Activation by insulin and amino acids of signaling components leading to translation initiation in skeletal muscle of neonatal pigs is developmentally regulated.
    Suryawan A, Orellana RA, Nguyen HV, Jeyapalan AS, Fleming JR, Davis TA.
    Am J Physiol Endocrinol Metab; 2007 Dec 13; 293(6):E1597-605. PubMed ID: 17878222
    [Abstract] [Full Text] [Related]

  • 52. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ.
    Acta Physiol (Oxf); 2009 May 13; 196(1):65-80. PubMed ID: 19245654
    [Abstract] [Full Text] [Related]

  • 53. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
    Fingar DC, Salama S, Tsou C, Harlow E, Blenis J.
    Genes Dev; 2002 Jun 15; 16(12):1472-87. PubMed ID: 12080086
    [Abstract] [Full Text] [Related]

  • 54. Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells.
    Lee HJ, Mariappan MM, Feliers D, Cavaglieri RC, Sataranatarajan K, Abboud HE, Choudhury GG, Kasinath BS.
    J Biol Chem; 2012 Feb 10; 287(7):4451-61. PubMed ID: 22158625
    [Abstract] [Full Text] [Related]

  • 55. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).
    García-Martínez JM, Moran J, Clarke RG, Gray A, Cosulich SC, Chresta CM, Alessi DR.
    Biochem J; 2009 Jun 12; 421(1):29-42. PubMed ID: 19402821
    [Abstract] [Full Text] [Related]

  • 56. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
    Liu Y, Fanburg BL.
    Am J Respir Cell Mol Biol; 2006 Feb 12; 34(2):182-91. PubMed ID: 16195541
    [Abstract] [Full Text] [Related]

  • 57. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X, Beugnet A, Murakami M, Yamanaka S, Proud CG.
    Mol Cell Biol; 2005 Apr 12; 25(7):2558-72. PubMed ID: 15767663
    [Abstract] [Full Text] [Related]

  • 58. S6K1 plays a key role in glial transformation.
    Nakamura JL, Garcia E, Pieper RO.
    Cancer Res; 2008 Aug 15; 68(16):6516-23. PubMed ID: 18701474
    [Abstract] [Full Text] [Related]

  • 59. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer.
    Kyou Kwon J, Kim SJ, Hoon Kim J, Mee Lee K, Ho Chang I.
    Urol Oncol; 2014 Jan 15; 32(1):51.e27-35. PubMed ID: 24239466
    [Abstract] [Full Text] [Related]

  • 60. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
    Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ.
    Am J Physiol Cell Physiol; 2009 Jun 15; 296(6):C1258-70. PubMed ID: 19357233
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.